Read the latest news from regional and global sources, presenting different voices and perspectives.
Take Control of Your Cash Flow: Proven Strategies for AR Leaders
Thank you for your interest in the webinar! Check your inbox for an email with instructions on viewing this on-demand presentation. Oops something went wrong. Watch Now {"LSQLeadFields":[{"Seq":1,"Name":"First...

Gilead Sciences gets European Commission marketing authorization for twice yearly Yeytuo for HIV prevention
Foster City: Gilead Sciences, Inc. has received the European Commission (EC) marketing authorization for Yeytuo (lenacapavir)-the company's twice-yearly injectable HIV-1 capsid inhibitor—for use as pre-exposure prophylaxis (PrEP) to reduce the...

European Commission Authorizes Twice-Yearly Yeytuo® (Lenacapavir) for HIV Prevention
– Yeytuo® is the First and Only European Commission (EC)-Authorized HIV PrEP Option Offering 6 Months of Protection – – Accelerated EC Decision Comes After U.S. FDA Approval in June – FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc....

Gilead Sciences' 99.9% Effective HIV Treatment Notches Another Win
Gilead Sciences (GILD) won European approval Tuesday for its new twice-annual HIV prevention shot, now called Yeytuo. The approval comes two months after the Food and Drug Administration signed off on Yeztugo, the drug's branded name in the U.S....

La Unión Europea aprueba una terapia inyectable semestral para la prevención del VIH
La Comisión Europea (CE) ha aprobado la comercialización de un fármaco inyectable como profilaxis previa a la exposición (PrEP) para reducir el riesgo de transmisión del VIH. El medicamento, un inyectable de administración semestral conocido...

Business News | Qatar Ready for Trade Deal Negotiations with India: Piyush Goyal
New Delhi [India], August 29 (ANI): Commerce Minister Piyush Goyal on Friday said Qatar is ready to start trade pact negotiations with India, which was initially indicated during the State Visit of Amir of Qatar, Sheikh Tamim bin Hamad Al-Thani,...
Biomanufacturing: Scale-up vs Scale-out Economics
Thank you for your interest in the webinar! Check your inbox for an email with instructions on viewing the on-demand presentation. Oops something went wrong. Watch Now {"LSQLeadFields":[{"Seq":1,"Name":"First...
4 major trends shaping today’s oncology market
Thank you for your interest in the webinar! Check your inbox for an email with instructions on viewing this on-demand presentation. Oops something went wrong. Watch Now {"LSQLeadFields":[{"Seq":1,"Name":"First...
The interplay of membrane tension and FtsZ filament condensation on the initiation and progression of cell division in B. subtilis
The ability of cells to divide into two is an essential process for all organisms, and accordingly, every cell examined so far encodes a machinery to facilitate its division. At the physical level, any cell division apparatus must first exert...

Deja Vu? Colorado’s Special Session Ends with Budget Tweaks, But Again No Long-Term AI Deal
Last Thursday, Aug. 21, the Colorado General Assembly reconvened for its 2025 Extraordinary Session, mostly focused on addressing the $750‒$800 million state budget shortfall created by the federal government’s passage of the One Big Beautiful...
The Digital Shift: Redefining Insurance with Smarter Payments
Thank you for your interest in the webinar! Check your inbox for an email with instructions on viewing the on-demand presentation. Oops something went wrong. Watch Now {"LSQLeadFields":[{"Seq":1,"Name":"First...

European Commission approves twice-yearly HIV injection lenacapavir, paving way
The European Commission approves lenacapavir, a twice-yearly HIV prevention injection, for rollout across the EU. Sold as Yeytuo, it offers a breakthrough alternative to daily PrEP, addressing rising HIV cases across Europe. The European...

World News | European Commission Approves Twice-yearly HIV Injection Lenacapavir, Paving Way for EU Rollout
Brussels [Belgium], August 27 (ANI): The European Commission has formally approved a twice-yearly injection to prevent HIV, paving the way for its rollout across the European Union, Euro News reported, citing drugmaker Gilead. The new treatment...
European Commission approves twice-yearly HIV injection lenacapavir, paving way for EU rollout
Brussels [Belgium], August 27 (ANI): The European Commission has formally approved a twice-yearly injection to prevent HIV, paving the way for its rollout across the European Union, Euro News reported, citing drugmaker Gilead. The new treatment...

New laws aim to crack down on tax avoidance, tax breaks for corporations and helps fill $1 billion revenue hole created by Congressional Republicans’ budget
Bills Crack Down on Foreign Tax Havens, Close Tax Breaks for Corporations, Protect Critical Services This morning, Governor Jared Polis signed two bills into law, intended to protect core services and close corporate tax loopholes after...

Implantica Publishes Interim Report January - June 2025 (Q2)
(MENAFN- PR Newswire) VADUZ, Liechtenstein, Aug. 14, 2025 /PRNewswire/ -- Transforming Clinical Excellence of RefluxStop® into Strategic Market Momentum Significant events in the second quarter of 2025 FDA PMA Submission Completed - Submitted...

50% US Tariff Comes Into Effect: Rs 5.4 Lakh Crore Indian Exports at Risk, Jobs and Sectors Under Pressure
New Delhi, 27th August 2025: Starting today, a steep 50% tariff has come into force on goods exported from India to the United States, dealing a heavy blow to Indian industries that rely on the American market. According to the Global Trade...

European Commission Greenlights UM171 Cell Therapy for Hematologic Malignancies
The European Commission has granted conditional approval to UM171 cell therapy (Zemcelpro) for the treatment of patients with hematologic malignancies who require allogeneic hematopoietic stem cell transplantation (HSCT) after myeloablative...

Ivoclar Summer School Highlights Global Collaboration
The Ivoclar Group, one of the world’s leading manufacturers of integrated solutions for high-quality dental applications with an extensive product and systems portfolio for dentists, dental technicians, and dental hygienists, once again...

ImmunityBio Wins U.K. Approval
Culver City-based ImmunityBio Inc. has started to take its Anktiva immunotherapy drug global. Last month, the United Kingdom Medicines and Healthcare Products Regulatory Agency approved Anktiva for treatment alongside a bacterial therapy for...